Fundamental Analysis
39 / 100BRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | -1.2% | +61.8% | 2 / 3 | +1.2% | -1.04 pp | -0.23 pp | +5.8% | 1.00 | 11.36 | 91,5 | +1,2% | 8,8 | −1,2% | 11.36 | 12.24 | −7,2% |
| Pts | 0 | 12 | 8 | 0 | 4 | 4 | 0 | 6 | 8 | |||||||
Valuation annotation:Price: 13.100 (close price on 2026-10-16)EPS (TTM): 1.153
Financial charts
1.Revenue & growth
VND bn91,5Q2/26
1.Revenue & growth
VND bn91,5Q2/26
2.Profit & growth
VND bn5,99Q2/26
3.Profit mix (Penman)
VND bn15,6Q2/26
4.Margins & cost structure
%37.5%Q2/26
5.Returns & cash cycle
% · days3.1%Q2/26
6.Earnings quality & cash
VND bn-39,7Q2/26
7.Asset structure
VND bn823Q2/26
8.Funding & debt health
VND bn · times823Q2/26
9.Revenue backlog
VND bn1,92Q2/26
10.Valuation
times · %13,4×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %375Q2/26
Adjusted EPS growth, latest quarter
-32.8%
Average adjusted EPS growth, 3 quarters
22.2%
averaged over 2 quarter(s)
Quarters at 25%+ growth
2/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26